Oct 1, 2026 08:00AM
Sep 2, 2025 07:32AM
Sep 2, 2025 07:30AM
Aug 11, 2025 09:26AM
Aug 11, 2025 09:26AM
Jun 18, 2025 08:00AM
May 2, 2023 07:30AM PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine) for the Treatment of Parkinson’s Disease
Apr 3, 2023 07:00AM
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM
Feb 1, 2023 11:25AM
Jan 18, 2023 08:15AM PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
Jan 11, 2023 08:15AM
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM
Nov 1, 2022 07:00AM
Oct 5, 2022 07:00AM
Sep 29, 2022 07:00AM
Sep 16, 2022 07:00AM PharmaTher Announces Late-Breaking Abstract Presentation of Positive Efficacy and Safety Data from Phase 1/2 Clinical Study of Ketamine in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s
Sep 7, 2022 07:00AM
Jul 13, 2022 07:00AM
Jun 29, 2022 07:00AM
Jun 7, 2022 07:00AM
May 25, 2022 07:00AM
May 5, 2022 07:00AM
Apr 25, 2022 05:06PM PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update
Apr 12, 2022 07:00AM
Mar 23, 2022 07:00AM
Mar 1, 2022 08:19AM
Feb 16, 2022 07:00AM
Feb 1, 2022 07:00AM
Jan 17, 2022 08:17AM
Jan 12, 2022 07:00AM PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS
Jan 4, 2022 07:00AM
Dec 21, 2021 07:00AM
Dec 20, 2021 07:00AM
Dec 14, 2021 07:00AM
Nov 30, 2021 07:00AM
Nov 24, 2021 07:30AM
Nov 11, 2021 07:59AM PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch
Nov 3, 2021 07:30AM
Nov 3, 2021 07:00AM
Nov 1, 2021 09:30AM
Oct 27, 2021 05:34PM
Oct 27, 2021 08:49AM
Oct 19, 2021 07:00AM
Oct 13, 2021 07:00AM PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome
Oct 6, 2021 09:03AM

332,794 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All